Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank31
3Y CAGR-28.9%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-28.9%/yr
vs +1.8%/yr prior
Acceleration
-30.7pp
Decelerating
Percentile
P31
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.04% |
| Q3 2025 | 2.51% |
| Q2 2025 | 2.78% |
| Q1 2025 | -1.43% |
| Q4 2024 | 5.53% |
| Q3 2024 | 2.79% |
| Q2 2024 | -0.12% |
| Q1 2024 | 8.20% |
| Q4 2023 | 1.05% |
| Q3 2023 | 1.42% |
| Q2 2023 | 8.28% |
| Q1 2023 | 6.61% |
| Q4 2022 | 5.68% |
| Q3 2022 | 4.96% |
| Q2 2022 | 3.99% |
| Q1 2022 | 5.27% |
| Q4 2021 | 3.72% |
| Q3 2021 | 3.57% |
| Q2 2021 | 3.61% |
| Q1 2021 | 7.41% |
| Q4 2020 | -0.28% |
| Q3 2020 | 3.19% |
| Q2 2020 | -2.18% |
| Q1 2020 | 6.41% |
| Q4 2019 | 0.66% |
| Q3 2019 | 5.35% |
| Q2 2019 | 1.69% |
| Q1 2019 | 6.38% |
| Q4 2018 | 2.65% |
| Q3 2018 | -0.99% |
| Q2 2018 | -0.30% |
| Q1 2018 | 7.07% |
| Q4 2017 | 3.99% |
| Q3 2017 | 1.79% |
| Q2 2017 | 0.56% |
| Q1 2017 | 5.50% |
| Q4 2016 | 5.53% |
| Q3 2016 | 5.91% |
| Q2 2016 | 3.99% |
| Q1 2016 | 6.17% |